--- title: "Senate report finds mifepristone makers fail safety oversight" publication: "MediaBias News" url: "https://mediabias.news/politics/senate-report-finds-mifepristone-makers-fail-safety-oversight" api: "https://mediabias.news/api/v1/stories/senate-report-finds-mifepristone-makers-fail-safety-oversight" markdown: "https://mediabias.news/politics/senate-report-finds-mifepristone-makers-fail-safety-oversight.md" audio: "https://mediabias.news/api/audio/senate-report-finds-mifepristone-makers-fail-safety-oversight" category: "Politics" published: "2026-08-27T17:45:44.094Z" source_reported: "2026-08-27T16:06:37.000Z" updated: "2026-08-27T17:45:44.094Z" trust_score: 60 critic_score: 60 hype_score: 45 assessment_type: "coverage-and-source-reporting-analysis" fact_check_status: "not-performed" coverage_measured: "2026-08-27T18:50:27.655Z" --- # Senate report finds mifepristone makers fail safety oversight *Investigation led by Senator Bill Cassidy details concerns with online sales and prescriber auditing.* **Scores for the source reporting** (0-100, assessing the original journalism this article was written from, not this write-up): - Trust 60 of 100, higher is better. Central claims attributed to named bodies and specific figures are provided, but sourcing is primarily from one committee report. - Craft 60 of 100, higher is better. Reporting includes quotes from affected parties and names specific entities, but lacks comment from all responsible parties. - Hype 45 of 100, lower is better. Headlines and language suggest strong criticism, but the body of the report is more measured. Scored by MediaBias News; method at https://mediabias.news/methodology. **The short version** - A Senate committee investigation found that manufacturers of the abortion pill mifepristone are not adequately upholding safety protocols, especially for online sales. - The report, led by Senator Bill Cassidy, accuses companies of failing to audit prescribers and report adverse events. - The Biden administration's expansion of mail-order access to mifepristone during the COVID-19 pandemic is identified as a contributing factor to increased online sales. - The findings have prompted calls for legal and regulatory authorities to take action concerning the oversight of abortion pill manufacturers. An investigation by the Senate Health, Education, Labor and Pensions Committee has found that manufacturers of the abortion pill mifepristone are not adhering to required safety strategies, particularly when the drug is sold online. The report, led by Senator Bill Cassidy, identified issues with manufacturers not auditing prescribers or reporting non-fatal adverse events. The investigation focused on three manufacturers: Danco Corporation, GenBioPro, and Evita Solutions. The report states that the expansion of mail-order access to mifepristone during the COVID-19 pandemic has contributed to a rise in online sales, creating potential for coercion and abuse. The committee's findings have led to calls for legal and regulatory bodies to address the oversight of these companies. ## Disagreement on prescribing limits The website Aid Access advertises prescribing mifepristone up to 14 weeks of pregnancy, which is beyond the 10-week limit set by the Food and Drug Administration. Roll Call reported that Senator Cassidy's report stated it was unclear who was providing the drug when ordered online and whether those parties were certified in the FDA's Risk Evaluation and Mitigation Strategy program. LifeNews.com reported that 81% of online abortion businesses send mifepristone far beyond the FDA's 10-week timeframe, citing research from the Charlotte Lozier Institute. ## What the coverage left out None of the centre or right-rated reports mentioned the specific figure of $1.2bn in profits that GenBioPro reportedly makes annually, as stated in the Washington Examiner's digest. The digests also did not include the specific details of the legal case Louisiana v. FDA, beyond mentioning it is set to resume on September 9. ## Who covered it Shares of the 8 covering outlets with a published leaning rating: - Left: 0% (0) - Centre: 37% (3) - Right: 63% (5) 0 of 8 covering outlets carried no usable leaning rating and were excluded from those percentages. Coverage measured 2026-08-27T18:50:27.655Z. **Coverage watch:** developing. Checked 8 times; 0 checks found a material change. Most recently checked 2026-08-27T19:46:14.901Z. ## How the sides framed it ### Left No separate framing summary. ### Centre - The centre-rated reports led on Senator Bill Cassidy's accusation that abortion pill manufacturers are failing to meet their legal obligations for safety compliance, especially with online sales through third parties. Both Roll Call and STAT News highlighted Cassidy's report, which calls for legal and regulatory authorities to take action. Roll Call noted that Cassidy, who is leaving Congress in January, accuses manufacturers of allowing third-party retailers to sell drugs without oversight and failing to report non-fatal adverse events. STAT News mentioned the report puts the high-profile issue on Heidi Overton as she faces confirmation as FDA commissioner. ### Right - Right-rated reports focused on the alleged dangers and lack of oversight associated with abortion pill manufacturers and online sales. LifeNews.com's headline stated that companies are selling 'Dangerous Abortion Pills to Kill Babies Up to Birth' and quoted Susan B. Anthony Pro-Life America calling for the Department of Justice to end mail-order mifepristone. The Washington Examiner reported that manufacturers are 'shirk[ing] oversight responsibility while making millions'. The Daily Signal reported that Cassidy 'Exposes Abortion Drug Companies Endangering Mothers'. LifeNews.com also cited incidents of alleged harm, including a Texas man facing charges after allegedly giving abortion drugs to a woman at approximately 14 weeks of pregnancy, and a case in North Carolina where a 31-week-old baby was born after the mother ordered drugs online. **Provisional coverage gap:** left. The watch is not closed, so this is not yet a settled blindspot finding. ## Factuality profile of the covering outlets These are published factuality ratings of the outlets, not a verdict on whether this story or its claims are true. - low: 2 - mixed: 2 - high: 1 - veryHigh: 3 ## Verification scope This page compares coverage and scores the source reporting. It is not a ClaimReview verdict on whether the underlying event or claim is true. ## Original reporting this was written from - [WND](https://wnd.com/2026/08/putting-mothers-risk-senator-doctors-report-documents-abortion) — Putting mothers at risk: Senator-doctor’s report documents abortion drug companies endangering women * WorldNetDaily * by Virginia Grace McKinnon, The Daily Signal - [union-bulletin.com](https://union-bulletin.com/news/national/cassidy-says-abortion-pill-makers-turn-blind-eye-to-safety/article_4691eebe-ea56-5c00-b580-895908375e50.html) — Cassidy says abortion pill makers turn blind eye to safety - [LifeNews.com](https://lifenews.com/2026/08/27/study-shows-companies-selling-dangerous-abortion-pills-to-kill-babies-up-to-birth) — Study Shows Companies Selling Dangerous Abortion Pills to Kill Babies Up to Birth - [Washington Times](https://washingtontimes.com/news/2026/aug/27/senate-committees-abortion-drug-probe-reveals-oversight-concerns) — Senate committee’s abortion drug probe reveals oversight concerns - [Washington Examiner](https://washingtonexaminer.com/policy/healthcare/4701912/abortion-pill-makers-shirk-oversight-responsibility-while-making-millions-senate-gop-finds) — Abortion pill makers shirk oversight responsibility while making millions, Senate GOP finds - [STAT](https://statnews.com/2026/08/27/bill-cassidy-louisiana-senator-new-report-mifepristone-heidi-overton) — Cassidy criticizes FDA oversight of abortion pill manufacturers in new report - [The Daily Signal](https://dailysignal.com/2026/08/27/abortion-pill-endangering-mothers) — SCOOP: Cassidy Exposes Abortion Drug Companies Endangering Mothers in New Report - [Roll Call](https://rollcall.com/2026/08/27/cassidy-says-abortion-pill-makers-turn-blind-eye-to-safety) — Cassidy says abortion pill makers turn blind eye to safety ## Questions **What are the main findings of the Senate committee investigation into mifepristone manufacturers?** The Senate committee investigation found that manufacturers of the abortion pill mifepristone are not upholding required safety protocols, particularly for online sales. The report accuses companies of failing to audit prescribers and report non-fatal adverse events, calling for regulatory action. **Which companies were investigated for their role in mifepristone manufacturing and distribution?** The investigation by the Senate Health, Education, Labor and Pensions Committee focused on three mifepristone manufacturers: Danco Corporation, GenBioPro, and Evita Solutions. The report examined their adherence to safety regulations, especially concerning online sales. **What role did the Biden administration's policies play in the investigation's findings?** The report cites the Biden administration's expanded mail-order access to mifepristone during the COVID-19 pandemic as a factor contributing to increased online sales. This expansion is seen as having opened the door to potential coercion and abuse of women. --- MediaBias News — https://mediabias.news. Reproduced from https://mediabias.news/politics/senate-report-finds-mifepristone-makers-fail-safety-oversight. Please cite as: MediaBias News, "Senate report finds mifepristone makers fail safety oversight", https://mediabias.news/politics/senate-report-finds-mifepristone-makers-fail-safety-oversight